Evidence map›Paper›PMID 39770484›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

N-Glycoside of Indolo[2,3-

Nikolay Kalitin, Natalia Koroleva, Anna Lushnikova, Maria Babaeva, Nadezhda Samoylenkova, Ekaterina Savchenko, Galina Smirnova, Yulia Borisova, Alexander Kostarev, Aida Karamysheva and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nikolay KalitinLaboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.
Natalia KorolevaLaboratory of Oncogenomics, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.ORCID 0000-0003-1663-4270
Anna LushnikovaLaboratory of Oncogenomics, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Maria BabaevaMolecular Medicine, Universitätsmedizin Berlin, 10117 Berlin, Germany.
Nadezhda SamoylenkovaLaboratory of Molecular and Cellular Neurogenetics, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Ekaterina SavchenkoLaboratory of Molecular and Cellular Neurogenetics, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
Galina SmirnovaLaboratory of Biochemical Pharmacology and Tumor Models, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Yulia BorisovaLaboratory of Biochemical Pharmacology and Tumor Models, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Alexander KostarevMax Planck Institute for Biology, University of Tübingen, 72074 Tübingen, Germany.
Aida KaramyshevaLaboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.
Galina PavlovaLaboratory of Molecular and Cellular Neurogenetics, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.ORCID 0000-0002-6885-6601

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2024-561
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CDK1glioblastomaglycosylated indolocarbazolesLCS1269Myt1Wee1

Identifiers

PMID39770484
PMCPMC11676706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.